MoneyWorks4Me

Strides Shasun shuts production at API facility in Tamil Nadu

24 Nov 2015 Evaluate

Drug firm Strides Shasun has suspended the production at its API facility at Cuddalore in Tamil Nadu on account of Government orders. The company is working with the authorities to resume operations at the earliest.

The facility, which makes Active Pharmaceutical Ingredients (API), has been permitted to resume operations in all manufacturing production blocks except the new production block.

Strides Shasun is a vertically integrated global pharmaceutical Company headquartered in Bangalore. The company has four business verticals, viz., Regulated Markets, Emerging Markets, Institutional Business and Pharmaceutical Services & Active Ingredients.

 

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..